NICE approves monoclonal antibody dupilumab for severe asthma
The National Institute for Health and Care Excellence has approved the monoclonal antibody dupilumab for patients with severe asthma who do not respond to conventional treatments.1 Asthma charities…
Read Original Article: NICE approves monoclonal antibody dupilumab for severe asthma »
